Outset Medical, Inc. (NASDAQ:OM) CFO Sells $27,430.40 in Stock

Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed sold 34,288 shares of the stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total transaction of $27,430.40. Following the completion of the sale, the chief financial officer now directly owns 258,869 shares in the company, valued at approximately $207,095.20. This trade represents a 11.70 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Nabeel Ahmed also recently made the following trade(s):

• On Monday, January 13th, Nabeel Ahmed sold 29,031 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total value of $23,515.11.
• On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total value of $2,367.15.
• On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $3,376.80.

Outset Medical Trading Down 3.3 %

Shares of Outset Medical stock traded down $0.03 during trading on Wednesday, hitting $0.78. The stock had a trading volume of 951,459 shares, compared to its average volume of 2,184,304. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. The company has a market capitalization of $40.98 million, a PE ratio of -0.28 and a beta of 2.05. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.22. The stock has a 50 day simple moving average of $1.01 and a 200 day simple moving average of $1.28.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 target price on shares of Outset Medical in a research report on Tuesday, January 7th.

Institutional Trading of Outset Medical

Several hedge funds and other institutional investors have recently modified their holdings of the business. Millennium Management LLC boosted its stake in shares of Outset Medical by 58.8% during the 2nd quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock valued at $7,480,000 after buying an additional 719,412 shares during the period. GSA Capital Partners LLP raised its position in Outset Medical by 924.7% during the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after acquiring an additional 1,003,135 shares in the last quarter. Marshall Wace LLP lifted its stake in Outset Medical by 487.8% in the second quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock valued at $1,210,000 after acquiring an additional 260,740 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in Outset Medical in the second quarter worth approximately $827,000. Finally, Cubist Systematic Strategies LLC increased its stake in shares of Outset Medical by 228.3% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 200,939 shares of the company’s stock worth $774,000 after purchasing an additional 139,740 shares during the last quarter.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.